Home | All trials

[RDF data]
Trial NCT00608673

Resource URI: http://static.linkedct.org/resource/trials/NCT00608673
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/22823>
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/8557>
linkedct:brief_title Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
linkedct:condition <http://static.linkedct.org/resource/condition/3981>
linkedct:criteria Inclusion Criteria: - Patients harboring discoid lupus erythematosus lesions on their face or neck Exclusion Criteria: - Patients with discoid lupus erythematosus in the setting of systemic lupus erythematosus - Patients having a more disseminated disease
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age N/A
linkedct:eligibility_minimum_age N/A
linkedct:end_date November 2007
linkedct:enrollment 10 (xsd:int)
linkedct:firstreceived_date January 23, 2008
linkedct:has_dmc Yes
linkedct:id NCT00608673
linkedct:intervention <http://static.linkedct.org/resource/intervention/30533>
linkedct:intervention <http://static.linkedct.org/resource/intervention/56548>
rdfs:label Trial NCT00608673
linkedct:lastchanged_date February 6, 2008
linkedct:lead_sponsor_agency Shaheed Beheshti Medical University
linkedct:location <http://static.linkedct.org/resource/location/73082>
linkedct:nct_id NCT00608673
linkedct:number_of_arms 2 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Pimecrolimus 1% Cream vs. Betamethasone Valerate 0.1% Cream in the Treatment of Facial Discoid Lupus Erythematosus: a Double-Blind Randomized, Pilot Study.
linkedct:org_study_id 77
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/5449>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/1388>
foaf:page <http://clinicaltrials.gov/show/NCT00608673>
linkedct:phase N/A
linkedct:primary_completion_date July 2007
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/34485>
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/103370>
linkedct:source Shaheed Beheshti Medical University
linkedct:start_date April 2006
linkedct:study_design Treatment, Randomized, Double Blind (Subject, Caregiver), Parallel Assignment, Safety/Efficacy Study
linkedct:study_type Interventional
linkedct:summary Discoid lupus erythematosus lesions are commonly treated with corticosteroids, but corticosteroids may induce side effects such as thinning of the skin or scarring. Therefore, an alternative medication with the same efficacy, but without the side-effects is sought after. Pimecrolimus is a newer drug specially designed to treat inflammatory diseases of skin. Its efficacy in treating discoid lupus erythematosus has not been studied extensively yet. However studies performed till now show promising results. Long-term topical use of this medication has not shown any serious side-effects in other skin diseases. In this study we aimed at comparing pimecrolimus efficacy with that of a common therapeutic choice, betamethasone valerate 0.1% cream, to see if pimecrolimus can be used as an alternative medication in treating discoid lupus erythematosus.
rdf:type linkedct:trials
linkedct:verification_date January 2008